TP53 and gastric cancer: In summary, these results highlight pathway-specific differences in survival outcomes among NHW GC patients, with PI3K and TGF-Beta pathway alterations showing significant associations with poorer prognosis, whereas TP53, WNT, and RTK/RAS alterations did not appear to strongly influence survival outcomes.